Cargando…

Current and Emerging Strategies to Treat Urothelial Carcinoma

SIMPLE SUMMARY: Urothelial cell carcinoma (UCC) is the ninth most common cancer worldwide and in the US the fourth most common cancer, with ~82,000 new cases (~62,000 men) diagnosed annually leading to ~17,000 deaths/year (~12,000 men). While early-stage cases exhibit more favorable outcomes, the em...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rani, Berkha, Ignatz-Hoover, James J., Rana, Priyanka S., Driscoll, James J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571746/ https://www.ncbi.nlm.nih.gov/pubmed/37835580 http://dx.doi.org/10.3390/cancers15194886

Ejemplares similares

Targeting Proteasomes in Cancer and Infectious Disease: A Parallel Strategy to Treat Malignancies and Microbes
por: Ignatz-Hoover, James J., et al.
Publicado: (2022)

Therapeutics to harness the immune microenvironment in multiple myeloma
por: Ignatz-Hoover, James J., et al.
Publicado: (2022)

Deciphering mechanisms of immune escape to inform immunotherapeutic strategies in multiple myeloma
por: Swamydas, Muthulekha, et al.
Publicado: (2022)

Novel therapies emerging in oncology to target the TGF-β pathway
por: Kim, Byung-Gyu, et al.
Publicado: (2021)

Vactosertib, a novel TGF-β1 type I receptor kinase inhibitor, improves T-cell fitness: a single-arm, phase 1b trial in relapsed/refractory multiple myeloma
por: Malek, Ehsan, et al.
Publicado: (2023)

Current Strategies and Novel Therapeutic Approaches for Metastatic Urothelial Carcinoma
por: Mollica, Veronica, et al.
Publicado: (2020)

Current and Emerging Treatments for Urothelial Carcinoma: A Focus on Enfortumab Vedotin
por: Shafique, Muhammad Ashir, et al.
Publicado: (2023)

Emerging diagnostic and therapeutic strategies for urothelial carcinoma
por: Moschini, Marco, et al.
Publicado: (2021)

Nephron-Sparing Approaches in Upper Tract Urothelial Carcinoma: Current and Future Strategies
por: Ham, Won Sik, et al.
Publicado: (2022)

Immunotherapy for Urothelial Carcinoma: Current Status and Perspectives
por: Kitamura, Hiroshi, et al.
Publicado: (2011)

Emerging biomarkers for the diagnosis and monitoring of urothelial carcinoma
por: Miyake, Makito, et al.
Publicado: (2018)

Optimal Management of Upper Tract Urothelial Carcinoma: Current Perspectives
por: Leow, Jeffrey J, et al.
Publicado: (2020)

Precision Medicine to Treat Urothelial Carcinoma—The Way Forward
por: Luceno, Carvy Floyd, et al.
Publicado: (2023)

Road testing new CAR design strategies in multiple myeloma
por: Rana, Priyanka S., et al.
Publicado: (2022)

Current role of lymphadenectomy in the upper tract urothelial carcinoma
por: Alvarez-Maestro, Mario, et al.
Publicado: (2016)

Overview of histologic variants of urothelial carcinoma: current trends and narrative review on treatment outcomes
por: Ogbue, Olisaemeka, et al.
Publicado: (2022)

Current Knowledge on Genomic Profiling of Upper Tract Urothelial Carcinoma
por: De Lorenzis, Elisa, et al.
Publicado: (2021)

Prognostic and Predictive Factors in Advanced Urothelial Carcinoma Treated with Immune Checkpoint Inhibitors: A Review of the Current Evidence
por: Rebuzzi, Sara Elena, et al.
Publicado: (2021)

Novel and emerging approaches in the management of non-muscle invasive urothelial carcinoma
por: Yassaie, Omid, et al.
Publicado: (2021)

Current status of the focused series “Urothelial Carcinoma”
por: Yuk, Hyeong Dong, et al.
Publicado: (2020)

Neoadjuvant immunotherapy for muscle invasive urothelial bladder carcinoma: will it change current standards?
por: Renner, Alex, et al.
Publicado: (2021)

Treatment Strategy for Dialysis Patient with Urothelial Carcinoma
por: Huang, Yun-Ching, et al.
Publicado: (2021)

Combating Bacterial Biofilms: Current and Emerging Antibiofilm Strategies for Treating Persistent Infections
por: Abdelhamid, Ahmed G., et al.
Publicado: (2023)

Emerging biomarkers in urothelial carcinoma: Challenges and opportunities
por: Andreatos, Nikolaos, et al.
Publicado: (2020)

Naturally-Occurring Canine Invasive Urothelial Carcinoma: A Model for Emerging Therapies
por: Sommer, Breann C., et al.
Publicado: (2018)

Genomics and Immunomics in the Treatment of Urothelial Carcinoma
por: Mollica, Veronica, et al.
Publicado: (2022)

Biomarkers for Precision Urothelial Carcinoma Diagnosis: Current Approaches and the Application of Single-Cell Technologies
por: Hong, Michelle, et al.
Publicado: (2021)

Current laser therapy options for endoscopic treatment of upper tract urothelial carcinoma
por: Zollinger, Benjamin W., et al.
Publicado: (2023)

Current strategies to treat tuberculosis
por: Podany, Anthony T., et al.
Publicado: (2016)

Urothelial Carcinoma
por: Chow, Nan-Haw, et al.
Publicado: (2012)

Treatment Strategies and Metabolic Pathway Regulation in Urothelial Cell Carcinoma: A Comprehensive Review
por: Yang, Huang-Yu, et al.
Publicado: (2020)

Durvalumab for the management of urothelial carcinoma: a short review on the emerging data and therapeutic potential
por: Baldini, Capucine, et al.
Publicado: (2019)

Sarcomatoid urothelial carcinoma of the renal pelvis treated with immunotherapy
por: Anraku, Tsutomu, et al.
Publicado: (2023)

Efficacy of Immune Checkpoint Inhibitors in Upper Tract Urothelial Carcinomas: Current Knowledge and Future Directions
por: Thouvenin, Jonathan, et al.
Publicado: (2021)

Shutting off the fuel supply to target metabolic vulnerabilities in multiple myeloma
por: Rana, Priyanka S., et al.
Publicado: (2023)

Micropapillary Variant of Urothelial Carcinoma
por: Kwon, Ghee Young, et al.
Publicado: (2011)

Microcystic Variant of Urothelial Carcinoma
por: Venyo, Anthony Kodzo-Grey
Publicado: (2013)

Nested Variant of Urothelial Carcinoma
por: Venyo, Anthony Kodzo-Grey
Publicado: (2014)

Targeted Therapies in Advanced and Metastatic Urothelial Carcinoma
por: Katims, Andrew B., et al.
Publicado: (2022)

Current status of photodynamic technology for urothelial cancer
por: Inoue, Keiji, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_i89ic2jm4mf1gjgngeu6nhn4pb